Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Estimating the mean and variance from the median, range, and the size of a sample
2005 Standout
Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C
2010
Control of cancer-related anemia with erythropoietic agents:a review of evidence for improved quality of life and clinical outcomes
2003
Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients
2006
Mechanisms of type-I- and type-II-interferon-mediated signalling
2005 Standout
Pathogenesis, clinical features, and treatment advances in mastocytosis
2006
Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia
2008
I. Specificity of the glutathione S-transferases in the conversion of leukotriene A4 to leukotriene C4
1987 StandoutNobel
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
1997 Standout
Clinical Course of Patients With Relapsed Multiple Myeloma
2004
The Treatment of Multiple Myeloma
1994
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
1999 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Acute Myeloid Leukemia in the Elderly
2008
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
1999 Standout
Mutagenicity of anticancer drugs in mammalian germ cells
1996
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
2005
Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY
2006
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
2003
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
2010
Multiple Myeloma
2004
Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome
1995
Pharmacology and therapeutic potential of interferons
2012
Multiple myeloma
2000 Standout
Interferon alpha—a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity
2004
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
2002 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Factors influencing inclusion of patients with malignancies in clinical trials
2005
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
2009
Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses
2006
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Effect of Aminoglycoside and β‐Lactam Combination Therapy versus β‐Lactam Monotherapy on the Emergence of Antimicrobial Resistance: A Meta‐analysis of Randomized, Controlled Trials
2005
Immunity, Inflammation, and Cancer
2010 Standout
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA
2005
Treatment of hairy-cell leukemia
1990
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations
2002
Prevention of Venous Thromboembolism
2004 Standout
Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
2009
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
2004
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Interferons: mechanisms of action and clinical applications
2003
Erythropoietin for patients with malignant disease
2004
Epoetin alfa improves quality of life in patients with cancer
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Anemia of Chronic Disease
2005 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
1998
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology
2002
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Incentives and disincentives to participation by clinicians in randomised controlled trials
2007
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
2018
Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line.
2000
Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study
2005
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
Comparative Metabolic Studies of Phenacetin and Structurally-related Compounds in the Rat
1976 StandoutNobel
Multiple Myeloma
2010
Factors that limit the quality, number and progress of randomised controlled trials.
1999
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma
1997
Thalidomide in multiple myeloma
2005
Growth Factors and Cancer
1991 StandoutScience
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Metabolism of a biliary metabolite of phenacetin and other acetanilides by the intestinal microflora
1976 StandoutNobel
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Multiple Myeloma
2011 Standout
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
2006
Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003
2007
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
2002 Standout
Prediction of Glomerular Filtration Rate from Serum Creatinine, Age, Sex and Body Weight
1987
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
The Role of Glutathione and Glutathione S-Transferases in the Metabolism of Chemical Carcinogens and Other Electrophilic Agents
1979
Works of Stig Rödjer being referenced
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
2001
Granulocyte‐macrophage colony‐stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial
2004
Initial versus deferred melphalan‐prednisone therapy for asymptomatic multiple myeloma stage I — A randomized study
1993
Serum deoxythymidine kinase: no help in the diagnosis and prognosis of monoclonal gammopathy
1993
Recombinant interferon‐alpha‐2b treatment of hairy‐cell leukaemia: Experience with a low‐dose schedule
1988
Pulmonary side effects of interferon‐α therapy in patients with hematological malignancies
2003
Interferon alfa‐2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study
1995
Physicians' attitudes toward clinical trials and their relationship to patient accrual in a nordic multicenter study on myeloma
1996
Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres
1995
Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes
1993
Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades
1999
Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma
1990
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects
1987
Separation of p-Acetamidophenol Metabolites by Gel Filtration on Sephadex G 10
1968
The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
1986
Separation of Urinary Constituents of Low Molecular Weight on Sephadex G 10
1968
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.
2000
Renal function in patients treated with tobramycin-cefuroxime or tobramycin-penicillin G
1983